CRISPR Tech Selectively Shreds Cancer Cells, Including "Undruggable" Cancers

A possible cancer breakthrough drops, and the comments instantly turn into hope, hype, and side-eye

TLDR: Researchers say they’ve found a new way to make cancer cells with a common mutation destroy themselves, a big deal because that mutation appears in many hard-to-treat cancers. Commenters swung between hope and cynicism, with some calling it huge news and others warning it may still be far from actual patient treatment.

A new study says scientists built a gene-scissors system that can spot a common cancer mutation and basically make those damaged cells self-destruct. That mutation is tied to nearly half of all cancers, including some of the toughest cases like ovarian, pancreatic, and certain lung cancers. In plain English: instead of trying to "fix" a broken cancer defense system, the researchers are trying to wipe out the bad cells entirely. Big, dramatic, very sci-fi — and yes, the internet had feelings.

The biggest mood in the comments was a mix of desperate hope and hard-earned skepticism. One person said they got excited about a cancer breakthrough a decade ago and got laughed at for it, which pretty much sums up the emotional baggage around headlines like this. Another commenter immediately pumped the brakes, pointing out that the write-up sounds like this is probably still lab-dish territory, meaning real treatment for patients could still be years or even decades away. So the vibe was: amazing if true, but call me when it survives the real-world gauntlet.

Then the thread swerved into full internet drama. One commenter raged that society somehow funds ad tech and YouTube anti-ad-block crusades while cancer still waits for miracles. Another dropped a link to the preprint like the thread librarian. And in the spiciest detour, someone complained that Reddit had devolved into such a mess that people were debating whether curing cancer is even good. So yes: possible medical breakthrough up top, existential comment-section meltdown underneath.

Key Points

  • A Nature paper reports a CRISPR-based method to selectively destroy cancer cells carrying mutant p53, a mutation found in nearly half of all cancers according to the article.
  • The research involved the Innovative Genomics Institute, UC Berkeley, UC San Francisco, Gladstone Institutes, the University of Utah, and Utah State University.
  • The article frames p53 as a long-sought but difficult cancer target because tumor suppressor mutations are loss-of-function changes and have lacked effective drugs.
  • First author Jingkun Zeng developed the approach around eliminating abnormal cells rather than restoring broken tumor suppressor function.
  • The engineered CRISPR-Cas12a2 system detects mutation-specific RNA and then activates chromatin shredding to destroy the targeted cell.

Hottest takes

"they laughed at me for believing" — Ifkaluva
"prioritize this over adtech?" — sssilver
"It’s just a botnet now to manipulate elections" — sourcegrift
Made with <3 by @siedrix and @shesho from CDMX. Powered by Forge&Hive.